<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29922292</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-3224</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Promyelocytic Leukemia Restricts Enterovirus 71 Replication by Inhibiting Autophagy.</ArticleTitle><Pagination><StartPage>1268</StartPage><MedlinePgn>1268</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1268</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.01268</ELocationID><Abstract><AbstractText>The promyelocytic leukemia (PML) protein, also known as TRIM19, functions as a major organizer of PML nuclear bodies (NBs) in most mammalian cells and plays important roles in antiviral activities against both DNA and RNA viruses. In this study, we found that the downregulation of PML rendered HeLa cells more susceptible to infection by enterovirus 71 (EV71), and the overexpression of the PMLIII or PMLIV isoforms inhibited viral protein expression and resulted in viral titers that were 2-3 log units lower than those in the control. Using short interfering RNAs, the downregulation of either the PMLIII or PMLIV isoform increased both viral protein VP1 expression and viral production. The PML repression of EV71 replication was partially mediated by the inhibition of autophagy, and PML deficiency triggered autophagy. Furthermore, the EV71 infection resulted in a reduction in PML independent of the proteasome pathway. Instead, PML degradation was mediated by virus protease 3C<sup>pro</sup>. In conclusion, PML contributes to a cellular antiviral effect by inhibiting autophagy, which is countered by a disruption of promyelocytic leukemia protein-nuclear bodies mediated by viral protease 3C<sup>pro</sup>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Deyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Chunhong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071156">Promyelocytic Leukemia Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015473" MajorTopicYN="N">Leukemia, Promyelocytic, Acute</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071156" MajorTopicYN="N">Promyelocytic Leukemia Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3Cpro</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">interferon-&#x3b2;</Keyword><Keyword MajorTopicYN="N">promyelocytic leukemia</Keyword><Keyword MajorTopicYN="N">promyelocytic leukemia protein-nuclear bodies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29922292</ArticleId><ArticleId IdType="pmc">PMC5996053</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.01268</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol (2007) 8(12):1006&#x2013;16.10.1038/nrm2277</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2277</ArticleId><ArticleId IdType="pubmed">17928811</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A, et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene (1995) 11(12):2565&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">8545113</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller S, Matunis MJ, Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 17(1):61&#x2013;70.10.1093/emboj/17.1.61</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/17.1.61</ArticleId><ArticleId IdType="pmc">PMC1170358</ArticleId><ArticleId IdType="pubmed">9427741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavalai N, Stamminger T. New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta (2008) 1783(11):2207&#x2013;21.10.1016/j.bbamcr.2008.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2008.08.004</ArticleId><ArticleId IdType="pubmed">18775455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavalai N, Stamminger T. Interplay between herpesvirus infection and host defense by PML nuclear bodies. Viruses (2009) 1(3):1240&#x2013;64.10.3390/v1031240</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v1031240</ArticleId><ArticleId IdType="pmc">PMC3185544</ArticleId><ArticleId IdType="pubmed">21994592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venturini L, Stadler M, et al. Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 9(12):2027&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">8609713</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelbi-Alix MK, de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene (1999) 18(4):935&#x2013;41.10.1038/sj.onc.1202366</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1202366</ArticleId><ArticleId IdType="pubmed">10023669</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, Chao TT, et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell (2006) 24(3):341&#x2013;54.10.1016/j.molcel.2006.10.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2006.10.019</ArticleId><ArticleId IdType="pubmed">17081986</ArticleId></ArticleIdList></Reference><Reference><Citation>Saffert RT, Kalejta RF. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol (2006) 80(8):3863&#x2013;71.10.1128/JVI.80.8.3863-3871.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.8.3863-3871.2006</ArticleId><ArticleId IdType="pmc">PMC1440479</ArticleId><ArticleId IdType="pubmed">16571803</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppard KN, Emmott E, Cortese MS, Rich T. Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis. J Gen Virol (2009) 90(Pt 1):95&#x2013;104.10.1099/vir.0.005512-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.005512-0</ArticleId><ArticleId IdType="pubmed">19088278</ArticleId></ArticleIdList></Reference><Reference><Citation>Florin L, Schafer F, Sotlar K, Streeck RE, Sapp M. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology (2002) 295(1):97&#x2013;107.10.1006/viro.2002.1360</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2002.1360</ArticleId><ArticleId IdType="pubmed">12033769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunardi A, Gaboli M, Giorgio M, Rivi R, Bygrave A, Antoniou M, et al. A role for PML in innate immunity. Genes Cancer (2011) 2(1):10&#x2013;9.10.1177/1947601911402682</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1947601911402682</ArticleId><ArticleId IdType="pmc">PMC3111006</ArticleId><ArticleId IdType="pubmed">21779477</ArticleId></ArticleIdList></Reference><Reference><Citation>Djavani M, Rodas J, Lukashevich IS, Horejsh D, Pandolfi PP, Borden KL, et al. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol (2001) 75(13):6204&#x2013;8.10.1128/JVI.75.13.6204-6208.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.13.6204-6208.2001</ArticleId><ArticleId IdType="pmc">PMC114337</ArticleId><ArticleId IdType="pubmed">11390623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampin M, Simonin Y, Blondel B, Percherancier Y, Chelbi-Alix MK. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol (2006) 80(17):8582&#x2013;92.10.1128/JVI.00031-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00031-06</ArticleId><ArticleId IdType="pmc">PMC1563870</ArticleId><ArticleId IdType="pubmed">16912307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelbi-Alix MK, Quignon F, Pelicano L, Koken MHM, De The H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol (1998) 72(2):1043&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124576</ArticleId><ArticleId IdType="pubmed">9444998</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel D, Kheddache S, Lahaye X, Dianoux L, Chelbi-Alix MK. Resistance to rabies virus infection conferred by the PMLIV isoform. J Virol (2010) 84(20):10719&#x2013;26.10.1128/Jvi.01286-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Jvi.01286-10</ArticleId><ArticleId IdType="pmc">PMC2950589</ArticleId><ArticleId IdType="pubmed">20702643</ArticleId></ArticleIdList></Reference><Reference><Citation>Borden KL, Campbell Dwyer EJ, Salvato MS. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol (1998) 72(1):758&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109432</ArticleId><ArticleId IdType="pubmed">9420283</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannoni F, Damonte EB, Garcia CC. Cellular promyelocytic leukemia protein is an important dengue virus restriction factor. PLoS One (2015) 10(5):e0125690.10.1371/journal.pone.0125690</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125690</ArticleId><ArticleId IdType="pmc">PMC4427460</ArticleId><ArticleId IdType="pubmed">25962098</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Peng Q, Wan X, Sun H, Tang J. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation. J Cell Sci (2017) 130(20):3496&#x2013;506.10.1242/jcs.202879</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.202879</ArticleId><ArticleId IdType="pubmed">28851805</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Y, Monajembashi S, Shao A, Cui D, He W, Chen Z, et al. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation. J Biol Chem (2012) 287(36):30729&#x2013;42.10.1074/jbc.M112.374769</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.374769</ArticleId><ArticleId IdType="pmc">PMC3436317</ArticleId><ArticleId IdType="pubmed">22773875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X, Qiu M, Chen D, Zheng N, Jin Y, Wu Z. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antiviral Res (2014) 109:30&#x2013;41.10.1016/j.antiviral.2014.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.06.004</ArticleId><ArticleId IdType="pubmed">24971492</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Liu L, Lei X, Zhou Z, He B, Wang J. 3C protease of enterovirus D68 inhibits cellular defense mediated by interferon regulatory factor 7. J Virol (2016) 90(3):1613&#x2013;21.10.1128/JVI.02395-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02395-15</ArticleId><ArticleId IdType="pmc">PMC4719596</ArticleId><ArticleId IdType="pubmed">26608321</ArticleId></ArticleIdList></Reference><Reference><Citation>El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK. Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog (2014) 10(2):e1003975.10.1371/journal.ppat.1003975</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003975</ArticleId><ArticleId IdType="pmc">PMC3937294</ArticleId><ArticleId IdType="pubmed">24586174</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell (2010) 140(3):313&#x2013;26.10.1016/j.cell.2010.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.028</ArticleId><ArticleId IdType="pmc">PMC2852113</ArticleId><ArticleId IdType="pubmed">20144757</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo-Arozena A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy (2016) 12(1):1&#x2013;222.10.1080/15548627.2015.1100356</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1100356</ArticleId><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Xu W, Chen D, Feng C, Zhang L, Wang X, et al. Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication. Antiviral Res (2015) 124:43&#x2013;53.10.1016/j.antiviral.2015.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.09.016</ArticleId><ArticleId IdType="pubmed">26515789</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroui MA, Pampin M, Chelbi-Alix MK. Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies. J Virol (2011) 85(24):13164&#x2013;73.10.1128/JVI.05808-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05808-11</ArticleId><ArticleId IdType="pmc">PMC3233141</ArticleId><ArticleId IdType="pubmed">21994459</ArticleId></ArticleIdList></Reference><Reference><Citation>Short KR, Veldhuis Kroeze EJ, Reperant LA, Richard M, Kuiken T. Influenza virus and endothelial cells: a species specific relationship. Front Microbiol (2014) 5:653.10.3389/fmicb.2014.00653</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2014.00653</ArticleId><ArticleId IdType="pmc">PMC4251441</ArticleId><ArticleId IdType="pubmed">25520707</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LL, Shan C, Deng CL, Li XD, Shang BD, Ye HQ, et al. Development of a stable Gaussia luciferase enterovirus 71 reporter virus. J Virol Methods (2015) 219:62&#x2013;6.10.1016/j.jviromet.2015.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2015.03.020</ArticleId><ArticleId IdType="pubmed">25843263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK. Differential roles of PML isoforms. Front Oncol (2013) 3:125.10.3389/fonc.2013.00125</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2013.00125</ArticleId><ArticleId IdType="pmc">PMC3660695</ArticleId><ArticleId IdType="pubmed">23734343</ArticleId></ArticleIdList></Reference><Reference><Citation>Dales S, Eggers HJ, Tamm I, Palade GE. Electron microscopic study of the formation of poliovirus. Virology (1965) 26:379&#x2013;89.10.1016/0042-6822(65)90001-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(65)90001-2</ArticleId><ArticleId IdType="pubmed">14319710</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson WT. Viruses and the autophagy pathway. Virology (2015) 479-480:450&#x2013;6.10.1016/j.virol.2015.03.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.03.042</ArticleId><ArticleId IdType="pmc">PMC5917100</ArticleId><ArticleId IdType="pubmed">25858140</ArticleId></ArticleIdList></Reference><Reference><Citation>Jheng JR, Ho JY, Horng JT. ER stress, autophagy, and RNA viruses. Front Microbiol (2014) 5:388.10.3389/fmicb.2014.00388</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2014.00388</ArticleId><ArticleId IdType="pmc">PMC4122171</ArticleId><ArticleId IdType="pubmed">25140166</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards AL, Jackson WT. How positive-strand RNA viruses benefit from autophagosome maturation. J Virol (2013) 87(18):9966&#x2013;72.10.1128/JVI.00460-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00460-13</ArticleId><ArticleId IdType="pmc">PMC3754026</ArticleId><ArticleId IdType="pubmed">23760248</ArticleId></ArticleIdList></Reference><Reference><Citation>Munz C. Beclin-1 targeting for viral immune escape. Viruses (2011) 3(7):1166&#x2013;78.10.3390/v3071166</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3071166</ArticleId><ArticleId IdType="pmc">PMC3185790</ArticleId><ArticleId IdType="pubmed">21994775</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SC, Chang CL, Wang PS, Tsai Y, Liu HS. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J Med Virol (2009) 81(7):1241&#x2013;52.10.1002/jmv.21502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21502</ArticleId><ArticleId IdType="pmc">PMC7166624</ArticleId><ArticleId IdType="pubmed">19475621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YR, Wang PS, Wang JR, Liu HS. Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model. J Biomed Sci (2014) 21:80.10.1186/s12929-014-0080-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-014-0080-4</ArticleId><ArticleId IdType="pmc">PMC4237791</ArticleId><ArticleId IdType="pubmed">25139436</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 8(4):445&#x2013;544.10.4161/auto.19496</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.19496</ArticleId><ArticleId IdType="pmc">PMC3404883</ArticleId><ArticleId IdType="pubmed">22966490</ArticleId></ArticleIdList></Reference><Reference><Citation>Missiroli S, Bonora M, Patergnani S, Poletti F, Perrone M, Gafa R, et al. PML at mitochondria-associated membranes is critical for the repression of autophagy and cancer development. Cell Rep (2016) 16(9):2415&#x2013;27.10.1016/j.celrep.2016.07.082</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.07.082</ArticleId><ArticleId IdType="pmc">PMC5011426</ArticleId><ArticleId IdType="pubmed">27545895</ArticleId></ArticleIdList></Reference><Reference><Citation>Regad T, Chelbi-Alix MK. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene (2001) 20(49):7274&#x2013;86.10.1038/sj.onc.1204854</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1204854</ArticleId><ArticleId IdType="pubmed">11704856</ArticleId></ArticleIdList></Reference><Reference><Citation>El McHichi B, Regad T, Maroui MA, Rodriguez MS, Aminev A, Gerbaud S, et al. SUMOylation promotes PML degradation during encephalomyocarditis virus infection. J Virol (2010) 84(22):11634&#x2013;45.10.1128/JVI.01321-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01321-10</ArticleId><ArticleId IdType="pmc">PMC2977872</ArticleId><ArticleId IdType="pubmed">20826694</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog (2009) 5(9):e1000593.10.1371/journal.ppat.1000593</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by toll-like receptor 3. J Virol (2011) 85(17):8811&#x2013;8.10.1128/JVI.00447-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol (2013) 87(3):1690&#x2013;8.10.1128/JVI.01855-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog (2013) 9(3):e1003231.10.1371/journal.ppat.1003231</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Maul GG, Yu E, Ishov AM, Epstein AL. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J Cell Biochem (1995) 59(4):498&#x2013;513.10.1002/jcb.240590410</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.240590410</ArticleId><ArticleId IdType="pubmed">8749719</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong S, Salomoni P, Pandolfi PP. The transcriptional role of PML and the nuclear body. Nat Cell Biol (2000) 2(5):E85&#x2013;90.10.1038/35010583</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35010583</ArticleId><ArticleId IdType="pubmed">10806494</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell (2002) 108(2):165&#x2013;70.10.1016/S0092-8674(02)00626-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00626-8</ArticleId><ArticleId IdType="pubmed">11832207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A. Deconstructing PML-induced premature senescence. EMBO J (2002) 21(13):3358&#x2013;69.10.1093/emboj/cdf341</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdf341</ArticleId><ArticleId IdType="pmc">PMC126090</ArticleId><ArticleId IdType="pubmed">12093737</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellaire G, Bazett-Jones DP. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays (2004) 26(9):963&#x2013;77.10.1002/bies.20089</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.20089</ArticleId><ArticleId IdType="pubmed">15351967</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H. PML nuclear bodies and apoptosis. Oncogene (2004) 23(16):2819&#x2013;24.10.1038/sj.onc.1207533</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207533</ArticleId><ArticleId IdType="pubmed">15077145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribet D, Lallemand-Breitenbach V, Ferhi O, Nahori MA, Varet H, de The H, et al. Promyelocytic leukemia protein (PML) controls Listeria monocytogenes infection. mBio (2017) 8(1):e2179&#x2013;2116.10.1128/mBio.02179-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02179-16</ArticleId><ArticleId IdType="pmc">PMC5225316</ArticleId><ArticleId IdType="pubmed">28074026</ArticleId></ArticleIdList></Reference><Reference><Citation>Everett RD, Chelbi-Alix MK. PML and PML nuclear bodies: implications in antiviral defence. Biochimie (2007) 89(6&#x2013;7):819&#x2013;30.10.1016/j.biochi.2007.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2007.01.004</ArticleId><ArticleId IdType="pubmed">17343971</ArticleId></ArticleIdList></Reference><Reference><Citation>de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell (1991) 66(4):675&#x2013;84.10.1016/0092-8674(91)90113-D</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90113-D</ArticleId><ArticleId IdType="pubmed">1652369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakizuka A, Miller WH, Jr, Umesono K, Warrell RP, Jr, Frankel SR, Murty VV, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell (1991) 66(4):663&#x2013;74.10.1016/0092-8674(91)90112-C</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90112-C</ArticleId><ArticleId IdType="pubmed">1652368</ArticleId></ArticleIdList></Reference><Reference><Citation>Regad T, Saib A, Lallemand-Breitenbach V, Pandolfi PP, de The H, Chelbi-Alix MK. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J (2001) 20(13):3495&#x2013;505.10.1093/emboj/20.13.3495</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.13.3495</ArticleId><ArticleId IdType="pmc">PMC125516</ArticleId><ArticleId IdType="pubmed">11432836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouna L, Hernandez E, Bonte D, Brost R, Amazit L, Delgui LR, et al. Analysis of the role of autophagy inhibition by two complementary human cytomegalovirus BECN1/Beclin 1-binding proteins. Autophagy (2016) 12(2):327&#x2013;42.10.1080/15548627.2015.1125071</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1125071</ArticleId><ArticleId IdType="pmc">PMC4836022</ArticleId><ArticleId IdType="pubmed">26654401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke PY, Chen SS. Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases. World J Gastroenterol (2014) 20(19):5773&#x2013;93.10.3748/wjg.v20.i19.5773</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i19.5773</ArticleId><ArticleId IdType="pmc">PMC4024787</ArticleId><ArticleId IdType="pubmed">24914338</ArticleId></ArticleIdList></Reference><Reference><Citation>Talloczy Z, Jiang W, Virgin HW, IV, Leib DA, Scheuner D, Kaufman RJ, et al. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci U S A (2002) 99(1):190&#x2013;5.10.1073/pnas.012485299</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.012485299</ArticleId><ArticleId IdType="pmc">PMC117537</ArticleId><ArticleId IdType="pubmed">11756670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Zhang J, Si X, Gao G, Mao I, McManus BM, et al. Autophagosome supports coxsackievirus B3 replication in host cells. J Virol (2008) 82(18):9143&#x2013;53.10.1128/JVI.00641-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00641-08</ArticleId><ArticleId IdType="pmc">PMC2546883</ArticleId><ArticleId IdType="pubmed">18596087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Jiang X, Liu D, Fan Z, Hu X, Yan J, et al. Autophagy is involved in influenza A virus replication. Autophagy (2009) 5(3):321&#x2013;8.10.4161/auto.5.3.7406</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5.3.7406</ArticleId><ArticleId IdType="pubmed">19066474</ArticleId></ArticleIdList></Reference><Reference><Citation>Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest (2006) 116(8):2161&#x2013;72.10.1172/JCI26185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI26185</ArticleId><ArticleId IdType="pmc">PMC1523410</ArticleId><ArticleId IdType="pubmed">16886061</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell FD, Hamilton KD. Nutrient deprivation increases vulnerability of endothelial cells to proinflammatory insults. Free Radic Biol Med (2014) 67:408&#x2013;15.10.1016/j.freeradbiomed.2013.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.12.007</ArticleId><ArticleId IdType="pubmed">24334251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimini S, Rizzardini M, Biella G, Cantoni L. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. J Neurochem (2014) 129(3):413&#x2013;25.10.1111/jnc.12642</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12642</ArticleId><ArticleId IdType="pubmed">24359187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal (2011) 14(11):2179&#x2013;90.10.1089/ars.2010.3488</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2010.3488</ArticleId><ArticleId IdType="pmc">PMC3085947</ArticleId><ArticleId IdType="pubmed">20812860</ArticleId></ArticleIdList></Reference><Reference><Citation>Essick EE, Sam F. Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid Med Cell Longev (2010) 3(3):168&#x2013;77.10.4161/oxim.3.3.12106</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/oxim.3.3.12106</ArticleId><ArticleId IdType="pmc">PMC2952075</ArticleId><ArticleId IdType="pubmed">20716941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ (2004) 11(4):448&#x2013;57.10.1038/sj.cdd.4401359</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401359</ArticleId><ArticleId IdType="pubmed">14713959</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer (2005) 5(9):726&#x2013;34.10.1038/nrc1692</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1692</ArticleId><ArticleId IdType="pubmed">16148885</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant K, Saraya A, Venugopal SK. Oxidative stress plays a key role in butyrate-mediated autophagy via Akt/mTOR pathway in hepatoma cells. Chem Biol Interact (2017) 273:99&#x2013;106.10.1016/j.cbi.2017.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2017.06.001</ArticleId><ArticleId IdType="pubmed">28600122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ML, Weng SF, Kuo CH, Ho HY. Enterovirus 71 induces mitochondrial reactive oxygen species generation that is required for efficient replication. PLoS One (2014) 9(11):e113234.10.1371/journal.pone.0113234</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113234</ArticleId><ArticleId IdType="pmc">PMC4234665</ArticleId><ArticleId IdType="pubmed">25401329</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S, Cheng X, Lim JH, Liu Y, Kao HY. Control of antioxidative response by the tumor suppressor protein PML through regulating Nrf2 activity. Mol Biol Cell (2014) 25(16):2485&#x2013;98.10.1091/mbc.E13-11-0692</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E13-11-0692</ArticleId><ArticleId IdType="pmc">PMC4142619</ArticleId><ArticleId IdType="pubmed">24943846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Guo S, Liu Y, Chu H, Hakimi P, Berger NA, et al. Ablation of promyelocytic leukemia protein (PML) re-patterns energy balance and protects mice from obesity induced by a Western diet. J Biol Chem (2013) 288(41):29746&#x2013;59.10.1074/jbc.M113.487595</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.487595</ArticleId><ArticleId IdType="pmc">PMC3795272</ArticleId><ArticleId IdType="pubmed">23986437</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa-Kawakita M, Ferhi O, Soilihi H, Le Bras M, Lallemand-Breitenbach V, de The H. PML is a ROS sensor activating p53 upon oxidative stress. J Exp Med (2017) 214(11):3197&#x2013;206.10.1084/jem.20160301</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160301</ArticleId><ArticleId IdType="pmc">PMC5679165</ArticleId><ArticleId IdType="pubmed">28931625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho HY, Cheng ML, Weng SF, Chang L, Yeh TT, Shih SR, et al. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol (2008) 89(Pt 9):2080&#x2013;9.10.1099/vir.0.2008/001404-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/001404-0</ArticleId><ArticleId IdType="pubmed">18753216</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM, et al. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol (2005) 86(Pt 12):3263&#x2013;9.10.1099/vir.0.81195-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, He Y, Chen Y, Kung HF, He ML. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther (2011) 16(1):51&#x2013;8.10.3851/IMP1720</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1720</ArticleId><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YH, Lau KS, Kuo RL, Horng JT. dsRNA binding domain of PKR is proteolytically released by enterovirus A71 to facilitate viral replication. Front Cell Infect Microbiol (2017) 7:284.10.3389/fcimb.2017.00284</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00284</ArticleId><ArticleId IdType="pmc">PMC5487429</ArticleId><ArticleId IdType="pubmed">28702377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Xu H, Chen X, Li X, Wang X, Ding S, et al. Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection. Hum Genet (2014) 133(2):187&#x2013;97.10.1007/s00439-013-1367-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-013-1367-3</ArticleId><ArticleId IdType="pmc">PMC7088390</ArticleId><ArticleId IdType="pubmed">24085612</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Mallon S, Roizman B. PML plays both inimical and beneficial roles in HSV-1 replication. Proc Natl Acad Sci U S A (2016) 113(21):E3022&#x2013;8.10.1073/pnas.1605513113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605513113</ArticleId><ArticleId IdType="pmc">PMC4889406</ArticleId><ArticleId IdType="pubmed">27162364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee AV, Lopez P, Pandolfi PP, Roizman B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol (2003) 77(12):7101&#x2013;5.10.1128/JVI.77.12.7101-7105.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.12.7101-7105.2003</ArticleId><ArticleId IdType="pmc">PMC156157</ArticleId><ArticleId IdType="pubmed">12768029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YP, Wang YF, Wang JR, Huang SW, Yu CK. Enterovirus 71 blocks selectively type I interferon production through the 3C viral protein in mice. J Med Virol (2012) 84(11):1779&#x2013;89.10.1002/jmv.23377</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23377</ArticleId><ArticleId IdType="pubmed">22997081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol (2010) 84(16):8051&#x2013;61.10.1128/JVI.02491-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SR, Sarnow P. Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology (2003) 315(1):259&#x2013;66.10.1016/S0042-6822(03)00544-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(03)00544-0</ArticleId><ArticleId IdType="pubmed">14592777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelbi-Alix MK, Vidy A, El Bougrini J, Blondel D. Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies. J Interferon Cytokine Res (2006) 26(5):271&#x2013;80.10.1089/jir.2006.26.271</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2006.26.271</ArticleId><ArticleId IdType="pubmed">16689655</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer M, Stamminger T. Emerging role of PML nuclear bodies in innate immune signaling. J Virol (2016) 90(13):5850&#x2013;4.10.1128/JVI.01979-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01979-15</ArticleId><ArticleId IdType="pmc">PMC4907236</ArticleId><ArticleId IdType="pubmed">27053550</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla WV, Pinschewer DD, Klenerman P, Rousson V, Gaboli M, Pandolfi PP, et al. Effects of promyelocytic leukemia protein on virus-host balance. J Virol (2002) 76(8):3810&#x2013;8.10.1128/JVI.76.8.3810-3818.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.8.3810-3818.2002</ArticleId><ArticleId IdType="pmc">PMC136073</ArticleId><ArticleId IdType="pubmed">11907221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Chiang C, Chen TC, Wu CN, Hsu JT, Lee JC, et al. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J Biomed Sci (2004) 11(2):239&#x2013;48.10.1159/000076036</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000076036</ArticleId><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim AC, Luhur A, Tan TM, Chow VT, Poh CL. RNA interference against enterovirus 71 infection. Virology (2005) 341(1):72&#x2013;9.10.1016/j.virol.2005.06.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.06.047</ArticleId><ArticleId IdType="pubmed">16083932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>